Chest
Volume 152, Issue 2, August 2017, Pages 424-434
Journal home page for Chest

Contemporary Reviews in Critical Care Medicine
Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome

https://doi.org/10.1016/j.chest.2017.03.055Get rights and content
Under a Creative Commons license
open access

A typical hemolytic uremic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP) and other causes or conditions with thrombotic microangiopathy (TMA), such as disseminated intravascular coagulation or sepsis. Similarity in clinical presentation may hinder diagnosis and optimal treatment selection in the urgent setting in the ICU. However, there is currently no consensus on the diagnosis or treatment of aHUS for ICU specialists. This review aims to summarize available data on the diagnosis and treatment strategies of aHUS in the ICU to enhance the understanding of aHUS diagnosis and outcomes in patients managed in the ICU. To this end, a review of the recent literature (January 2009-March 2016) was performed to select the most relevant articles for ICU physicians. Based on the paucity of adult aHUS cases overall and within the ICU, no specific recommendations could be formally graded for the critical care setting. However, we recognize a core set of skills required by intensivists for diagnosing and managing patients with aHUS: recognizing thrombotic microangiopathies, differentiating aHUS from related conditions, recognizing involvement of other organ systems, understanding the pathophysiology of aHUS, knowing the diagnostic workup and relevant outcomes in critically ill patients with aHUS, and knowing the standard of care for patients with aHUS based on available data and guidelines. In conclusion, managing critically ill patients with aHUS requires basic skills that, in the absence of sufficient data from patients treated within the ICU, can be gleaned from an increasingly relevant literature outside the ICU. More data on critically ill patients with aHUS are needed to validate these conclusions within the ICU setting.

Key Words

atypical hemolytic uremic syndrome
eculizumab
intensive care
organ failure
plasma exchange
thrombocytopenia
thrombotic microangiopathy

Abbreviations

aHUS
atypical hemolytic uremic syndrome
C3
complement component 3
HUS
hemolytic uremic syndrome
STEC
Shiga toxin-producing Escherichia coli
STEC-HUS
Shiga toxin-associated hemolytic uremic syndrome
TMA
thrombotic microangiopathy
TTP
thrombotic thrombocytopenic purpura

Cited by (0)